GPT and lymphopenia: With the proposed XGB method, the factors associated with a worse outcome of tocilizumab use in terms of mortality were: baseline situation at the start of tocilizumab treatment requiring IMV, elevated ferritin, LDH and GPT, lymphopenia, and low PAFI values.